Form 4: Director Bridget A. Ross Reports Acquisition of Dividend Equivalent Rights in LeMaitre Vascular Inc.

Director Bridget A. Ross acquired dividend equivalent rights related to previously granted restricted stock units and performance share units in LeMaitre Vascular Inc.

Summary

• Bridget A. Ross, a director at LeMaitre Vascular Inc., reported the acquisition of dividend equivalent rights.
• These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
• The dividend equivalent rights vest proportionately with the underlying RSU and PSU awards.
• The transactions occurred on December 5, 2024.
• The acquired rights are economically equivalent to shares of LeMaitre Vascular Inc.'s common stock.

Sentiment

Score: 7

Explanation: The document is a routine filing of insider transactions, which is neither positive nor negative. The acquisition of dividend equivalent rights is a standard practice and does not indicate any significant change in the company's outlook.

Positives

• The acquisition of dividend equivalent rights indicates continued alignment of director's interests with shareholders.
• The vesting of these rights is tied to the performance and time-based vesting of the underlying awards, which is a standard practice.

Industry Context

This is a standard SEC Form 4 filing related to insider transactions, which is common for publicly traded companies. The acquisition of dividend equivalent rights is a typical component of executive compensation packages.

Comparison to Industry Standards

• The use of dividend equivalent rights is a common practice in executive compensation, particularly for companies that issue restricted stock units and performance share units.
• Many companies in the medical device industry, such as Medtronic and Boston Scientific, use similar equity-based compensation structures.
• The vesting schedules and terms of these rights are generally aligned with industry norms for executive compensation.

Stakeholder Impact

• The acquisition of dividend equivalent rights has a minor positive impact on the director's alignment with shareholder interests.
• The transaction does not have a direct impact on employees, customers, suppliers, or creditors.

Key Dates

Keywords

dividend equivalent rights, Form 4, insider trading, LeMaitre Vascular Inc, LMAT, director, Bridget A. Ross, restricted stock units, performance share units